Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Anderson Insider Profile
4 Followers
Thomas Anderson, at SAGE Therapeutics, holds 10.00K shares in Zevra Therapeutics (Ticker: ZVRA), holds 0.00 shares in SAGE Therapeutics (Ticker: SAGE). Most recently, Thomas Anderson Bought ― shares of Zevra Therapeutics on Sep 06, 2023 for an estimated value of 48.70K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+84.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas Anderson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thomas Anderson
Thomas Anderson's Trading History
SAGE Therapeutics
Dec 19, 2016
Uninformative Sell
16.95K
$0.00
Zevra Therapeutics
Sep 06, 2023
Director
Informative Buy
48.70K
$51.55K
List of latest transactions for each holding click on a transaction to see Thomas Anderson's performance on stock
You May Also Like
Thomas Anderson insider profile FAQ
What is the percentage of profitable transactions made by Thomas Anderson?
The percentage of profitable transactions made by Thomas Anderson is 50%.
What is the average return per transaction made by Thomas Anderson?
The average return per transaction made by Thomas Anderson is 84.90%.
What stocks does Thomas Anderson hold?
Thomas Anderson holds: SAGE, ZVRA stocks.
What was Thomas Anderson’s latest transaction?
Thomas Anderson latest transaction was an Informative Buy of $48.70K.
What was Thomas Anderson's most profitable transaction?
Thomas Anderson’s most profitable transaction was an Informative Buy of SAGE stock on July 23, 2014. The return on the trade was 173.30%.
What is Thomas Anderson's role in SAGE Therapeutics?
Thomas Anderson's role in SAGE Therapeutics is .
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.